481 related articles for article (PubMed ID: 17085104)
41. Botulinum toxin A for the treatment of delayed gastric emptying.
Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
Kuo HC
Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
[TBL] [Abstract][Full Text] [Related]
43. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E
J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405
[TBL] [Abstract][Full Text] [Related]
44. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup.
Giannantoni A; Porena M; Costantini E; Zucchi A; Mearini L; Mearini E
J Urol; 2008 Mar; 179(3):1031-4. PubMed ID: 18206941
[TBL] [Abstract][Full Text] [Related]
45. Injectable neuromodulatory agents: botulinum toxin therapy.
Frenkl TL; Rackley RR
Urol Clin North Am; 2005 Feb; 32(1):89-99. PubMed ID: 15698881
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms of prostate atrophy after glandular botulinum neurotoxin type a injection: an experimental study in the rat.
Silva J; Pinto R; Carvallho T; Coelho A; Avelino A; Dinis P; Cruz F
Eur Urol; 2009 Jul; 56(1):134-40. PubMed ID: 18649990
[TBL] [Abstract][Full Text] [Related]
47. Effects of purified newly developed botulinum neurotoxin type A in rat prostate.
Nishiyama Y; Yokoyama T; Tomizawa K; Okamura K; Yamamoto Y; Matsui H; Oguma K; Nagai A; Kumon H
Urology; 2009 Aug; 74(2):436-9. PubMed ID: 19371936
[TBL] [Abstract][Full Text] [Related]
48. What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.
Khan S; Kessler TM; Apostolidis A; Kalsi V; Panicker J; Roosen A; Gonzales G; Haslam C; Elneil S; Fowler CJ; Dasgupta P
J Urol; 2009 Apr; 181(4):1773-8. PubMed ID: 19233414
[TBL] [Abstract][Full Text] [Related]
49. Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?
da Silva CM; Cruz F
Curr Opin Urol; 2009 Jul; 19(4):347-52. PubMed ID: 19444121
[TBL] [Abstract][Full Text] [Related]
50. Botulinum toxin in ophthalmology.
Dutton JJ; Fowler AM
Surv Ophthalmol; 2007; 52(1):13-31. PubMed ID: 17212988
[TBL] [Abstract][Full Text] [Related]
51. Re: Athanassios Oeconomou, Helmut Madersbacher, Gustav Kiss, Thomas J. Berger, Michael Melekos and Peter Rehder. Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? a review of the literature. Eur Urol 2008;54:765-77.
Brisinda G; Vanella S; Maria G
Eur Urol; 2009 Jul; 56(1):e10-1; author reply e12-3. PubMed ID: 19375845
[No Abstract] [Full Text] [Related]
52. Botulinum toxin for the treatment of headaches: a review of current practices and evidence based-data.
Ateş Y
Agri; 2006 Jul; 18(3):5-11. PubMed ID: 17089224
[TBL] [Abstract][Full Text] [Related]
53. Treatment of tension-type headache with botox: a review of the literature.
Rozen D; Sharma J
Mt Sinai J Med; 2006 Jan; 73(1):493-8. PubMed ID: 16470328
[TBL] [Abstract][Full Text] [Related]
54. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population.
White WM; Pickens RB; Doggweiler R; Klein FA
J Urol; 2008 Dec; 180(6):2522-6. PubMed ID: 18930481
[TBL] [Abstract][Full Text] [Related]
55. Pharmacology of therapeutic botulinum toxin preparations.
Dressler D; Benecke R
Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
[TBL] [Abstract][Full Text] [Related]
56. Effects of botulinum toxin A on the contractile function of dog prostate.
Lin AT; Yang AH; Chen KK
Eur Urol; 2007 Aug; 52(2):582-9. PubMed ID: 17386969
[TBL] [Abstract][Full Text] [Related]
57. Botulinum toxins for facial wrinkles: beyond glabellar lines.
Dayan SH; Maas CS
Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
[TBL] [Abstract][Full Text] [Related]
58. [Use of botulinum neurotoxin for spasticity].
Mukai Y; Kaji R
Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
[TBL] [Abstract][Full Text] [Related]
59. [Benign prostatic hyperplasia--botulinum toxin A in BPH with small prostate volume].
Adler S
Aktuelle Urol; 2006 Sep; 37(5):315-6; discussion 315-6. PubMed ID: 17004177
[No Abstract] [Full Text] [Related]
60. [Botulinum A toxin in the treatment of patients with detrusor external sphincter dyssynergia and neurogenic low detrusor contractility].
Mazo EB; Krivoborodov GG; Efremov NS
Ter Arkh; 2008; 80(10):49-52. PubMed ID: 19105415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
